Mycronic AB

MYCR

Equity

ISIN SE0000375115 / Valor 659217

NASDAQ Nordic Exchange Stockholm, Equities (2024-11-20)

SEK 386.00+0.68%

Mycronic AB
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Mycronic AB is a Sweden-based global supplier specializing in the provision of high-precision production equipment for the electronics manufacturing sector. With a workforce exceeding 2,000 employees and a presence in over 50 countries, the company positions itself as a leader in delivering flexible, innovative production solutions tailored to the evolving needs of the electronics industry. Mycronic's offerings are distinguished by their focus on sustainability, high quality, and extended product life cycles, ensuring that their customers remain competitive in a rapidly advancing technological landscape. The company's commitment to innovation and customer-centric design underscores its role in pushing the boundaries of electronics technology, catering to a diverse and global clientele seeking efficient and reliable manufacturing solutions.

Summarized from source with an LLMView SourceSector: Technology

Order Intake

In the second quarter of 2024, Mycronic AB reported an order intake of SEK 2,125 million, marking a 22 percent increase from the previous year's SEK 1,748 million. This growth was primarily driven by the Pattern Generators segment, with additional positive contributions from High Flex and High Volume.

Net Sales

Mycronic AB's net sales for Q2 2024 increased by 23 percent to SEK 1,527 million, compared to SEK 1,245 million in Q2 2023. This growth was consistent even when adjusted for constant exchange rates, indicating strong performance across the board.

EBIT and EBIT Margin

For the second quarter of 2024, Mycronic AB's EBIT more than doubled to SEK 348 million from SEK 170 million in the same period the previous year. The EBIT margin also saw a significant improvement, rising to 23 percent from 14 percent in Q2 2023.

Earnings Per Share

Mycronic AB reported earnings per share of SEK 2.94 for the second quarter of 2024, a substantial increase from SEK 1.37 in Q2 2023. This reflects the company's strong financial performance and profitability during the period.

Outlook for 2024

The Board of Directors of Mycronic AB has adjusted its outlook for net sales in 2024, raising the expected level from SEK 6.25 billion to SEK 6.5 billion. This optimistic revision underscores the company's confidence in its continued growth and market position.

Summarized from source with an LLMView Source

Key figures

59.5%1Y

78.4%3Y

135%5Y

Performance

30.3%1Y

37.8%3Y

38.9%5Y

Volatility